|
|
News Breaks
|
November 14, 2011
|
| 09:44 EDT |  | PRAN |
| theflyonthewall.com: | Prana says PBT2 reverses loss of synaptic activity in neurons | | Prana Biotechnology announced that scientists from Merz Pharmaceuticals GmbH and the Max Planck Institute presented data showing that Prana's PBT2 improves synaptic activity in neurons needed for memory. The scientists presented their data at The Society for Neuroscience meeting in Washington D.C. The experiments reported that PBT2 was able to prevent synapatic toxicity or loss of signal conductivity, caused by the formation of toxic Aâ oligomers. The data indicates that it may be most beneficial for neuroprotective agents such as PBT2, that can interrupt Aâ self-assembly into aggregates, to be administered to early stage patients to best maintain synaptic plasticity and function as an effective treatment for Alzheimer's Disease. :theflyonthewall.com |
|
|
News For PRAN From The Last 14 Days Check below for free stories on PRAN the last two weeks.
| Sign up for a free trial to see the rest of the stories you've been missing. |
There are no results for these search parameters.
|
|
|
|
